CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, May 18, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and ...

IDEAYA Biosciences (NASDAQ:IDYA) said its lead oncology program remains on track for a regulatory submission after reporting positive top-line data in first-line metastatic melanoma, while also highli ...

By Kamal Choudhury and Christy Santhosh May 18 (Reuters) - U.S. President Donald Trump's executive order to accelerate ...

Doctors and patients complain that the controversial practice of prior authorization for treatment and procedures is still ...

Last month, Revolution Medicines’ RAS inhibitor doubled survival in a Phase 3 pancreatic cancer trial. On the biotech’s heels are Immuneering, Actuate Therapeutics, Erasca and more, looking to improve ...

LUND, SE / ACCESS Newswire / May 18, 2026 / Spago Nanomedical AB (publ)(STO:SPAGO.ST)(FRA:7UX.F) today announces that case findings from its ongoing Phase I/IIa clinical study Tumorad-01 have been pre ...

This year's Special 301 report took a meaningful step toward calling out misbehavior of adversaries and allies wherever it occurs.

New research presented at this year’s European Congress on Obesity in Istanbul, Turkey (12-15 May) shows the use of the new ...

Novartis today announced new data from PSMAddition demonstrating improved prostate-specific antigen (PSA) responses with ...

Brain scans revealed a hidden and more severe form of ADHD in children, characterized by significant emotional disturbances.